Log In
Print
BCIQ
Print
Print this Print this
 

lidocaine/tetracaine (Pliaglis)

  Manage Alerts
Collapse Summary General Information
Company Nuvo Research Inc.
DescriptionPhase-changing topical formulation of lidocaine and tetracaine
Molecular Target Sodium channel voltage-dependent
Mechanism of ActionNa channel blocker
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationAnesthesia
Indication DetailsNumb the skin before various medical procedures; Produce local anaesthesia on intact skin in adults prior to superficial dermatological procedures
Regulatory Designation

Partner

Galderma S.A.


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$36.6M

$0.2M

$23.6M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today